1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : PHARMACEUTICALS
  4. GLENMARK PHARMACEUTICALS LTD.
Glenmark Pharmaceuticals Ltd. NSE: GLENMARK | BSE: 532296
2181.10 277.10 (14.55%)
16.5M

NSE 11 Jul, 2025 3:31 PM (IST)

Signs Agreement
Glenmark rises as it licenses its cancer drug, ISB-2001, to AbbVie for up to $1.9 bn, royalties See details

Glenmark Pharmaceuticals Ltd. - Financial Ratios